Glucocorticoid-Induced Avascular Bone Necrosis: Diagnosis and Management
Open Access
- 5 October 2012
- journal article
- Published by Bentham Science Publishers Ltd. in The Open Orthopaedics Journal
- Vol. 6 (1), 449-457
- https://doi.org/10.2174/1874325001206010449
Abstract
Glucocorticoid use is one of the most important causes of avascular bone necrosis (AVN). The pathogenesis of glucocorticoid-induced AVN is not fully understood but postulated mechanisms include fat hypertrophy, fat emboli and intravascular coagulation that cause impedance of blood supply to the bones. Data regarding the relationship between AVN and dosage, route of administration and treatment duration of glucocorticoids are conflicting, with some studies demonstrating the cumulative dose of glucocorticoid being the most important determining factor. Early recognition of this complication is essential as the prognosis is affected by the stage of the disease. Currently, there is no consensus on whether universal screening of asymptomatic AVN should be performed for long-term glucocorticoid users. A high index of suspicion should be exhibited for bone and joint pain at typical sites. Magnetic resonance imaging (MRI) or bone scintigraphy is more sensitive than plain radiograph for diagnosing early-stage AVN. Conservative management of AVN includes rest and reduction of weight bearing. Minimization of glucocorticoid dose or a complete withdrawal of the drug should be considered if the underlying conditions allow. The efficacy of bisphosphonates in reducing the rate of collapse of femoral head in AVN is controversial. Surgical therapy of AVN includes core decompression, osteotomy, bone grafting and joint replacement. Recent advances in the treatment of AVN include the use of tantalum rod and the development of more wear resistant bearing surface in hip arthroplasty.Keywords
This publication has 82 references indexed in Scilit:
- The incidence of alcohol-associated osteonecrosis of the knee is lower than the incidence of steroid-associated osteonecrosis of the knee: an MRI studyRheumatology, 2011
- Midterm Results of Primary Total Hip Arthroplasty Using Highly Cross-Linked PolyethyleneThe Journal of Arthroplasty, 2011
- Ten-Year Follow-Up of Avascular Necrosis of Femoral Head Treated With Alendronate for 3 YearsThe Journal of Arthroplasty, 2011
- Effect of simvastatin on steroid-induced osteonecrosis evidenced by the serum lipid level and hepatic cytochrome P4503A in a rabbit modelJournal of Orthopaedic Science, 2008
- Long-term Followup of Vascularized Fibular Grafting for Femoral Head NecrosisClinical Orthopaedics & Related Research, 2008
- Osteonecrosis in patients with systemic lupus erythematosus: MR imaging and scintigraphic evaluationClinical Imaging, 2004
- Alcohol-Induced Adipogenesis in Bone and Marrow: A Possible Mechanism for OsteonecrosisClinical Orthopaedics & Related Research, 2003
- Hyperbaric oxygen therapy as a treatment for stage-I avascular necrosis of the femoral headThe Journal of Bone and Joint Surgery. British volume, 2003
- Risk Period for Developing Osteonecrosis of the Femoral Head in Patients on Steroid TreatmentClinical Rheumatology, 2002
- Does avascular necrosis cause collapse of the dome of the talus in severe haemophilia?Haemophilia, 1999